
Marcia F. T. Rupnow, PhD
Advertisement
Articles by Marcia F. T. Rupnow, PhD
Advertisement
Latest Updated Articles
Participating Faculty: Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes MellitusPublished: October 26th 2014 | Updated:
Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes MellitusPublished: October 26th 2014 | Updated:
Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical TrialsPublished: December 16th 2014 | Updated:
Attainment of Diabetes-Related Quality Measures With Canagliflozin Versus SitagliptinPublished: January 25th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
2
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
Making the Genetic Models Match the Ancestry of Patient Populations
5



